IFP Advisors’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,026
| Closed | -$112K | – | 5047 |
|
|
2025
Q3 | $112K | Buy |
10,026
+387
| +4% | +$4.29K | ﹤0.01% | 1616 |
|
|
2025
Q2 | $117K | Buy |
9,639
+1,401
| +17% | +$7.99K | ﹤0.01% | 1545 |
|
|
2025
Q1 | $37.8K | Hold |
8,238
| – | – | ﹤0.01% | 2021 |
|
|
2024
Q4 | $46.6K | Buy |
8,238
+8,237
| +823,700% | +$46.5K | ﹤0.01% | 1865 |
|
|
2024
Q3 | $5 | Hold |
1
| – | – | ﹤0.01% | 3291 |
|
|
2024
Q2 | $5 | Hold |
1
| – | – | ﹤0.01% | 3219 |
|
|
2024
Q1 | $13 | Hold |
1
| – | – | ﹤0.01% | 3098 |
|
|
2023
Q4 | $14 | Hold |
1
| – | – | ﹤0.01% | 3018 |
|
|
2023
Q3 | $13 | Sell |
1
-5
| -83% | -$81 | ﹤0.01% | 3270 |
|
|
2023
Q2 | $112 | Buy |
+6
| New | +$100 | ﹤0.01% | 3348 |
|
|
2023
Q1 | – | Sell |
-100
| Closed | -$3K | – | 4407 |
|
|
2022
Q4 | $3K | Buy |
+100
| New | +$2.65K | ﹤0.01% | 4070 |
|
